SUPERCAIR
510(k) K890523
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK890523 | Date10 Feb 1989 | StatusActive |
Official records
- FDA 510(k) database K890523
From the FDA record
- Received by the FDA
- 2 Feb 1989
- FDA decision
- 10 Feb 1989 (Substantially Equivalent)
- FDA review time
- 8 days from receipt to decision
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- INX
- Device class
- Class II
- Regulation
- 21 CFR Part 890.5160
- Advisory committee
- Physical Medicine
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 23 Sep 2026
The SUPERCAIR is an air fluidized bed, a device type used in physical medicine for patient support and pressure redistribution. It is designed to provide therapeutic support through fluidized air circulation.
The device is supplied as a reusable system intended for use in clinical settings. It has received FDA 510(k) clearance under product code INX and regulation number 890.5160, with a traditional clearance pathway and SESE decision code.
Similar devices
Other devices filed under FDA product code INX (Bed, Air Fluidized).
- Microair Fluidized Air Bed by Gsi Development Co.
- Comfort Care Low Air Loss Therapy Bed by Ch Administration, Inc.
- Stage IV Air-Fluidize Bed by Unique Flotation Systems, Inc.
- Skytron Model 610-2 by Skytron, Div. the Kmw Group, Inc.
- Dermatek 4000 by Anacom General Corp.
- REM-AIR by Mellenair Ent., Inc.
- CLINITRON AIR FLUIDIZED SUPPORT SYSTEM by Uhi Corp.
- TASSI MK2 by Therapy Air Support Systems, Inc.
- CLINITRON C-II by Support Systems Intl.
- AIR PLUS AIR FLUIDIZED THERAPY SYSTEMS by Air Plus, Inc.